Treatments for somnambulism in adults: Assessing the evidence

Sleep Medicine Reviews

Volumn 13, Issue 4, 2009, Pages 295-297

  Harris, Melanie ^a   Grunstein, Ronald R ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clinical trials; Evidence based medicine; Somnambulism

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; ESTAZOLAM; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; ZOLPIDEM;

ADULT; CLINICAL RESEARCH; DRUG EFFICACY; EVIDENCE BASED MEDICINE; GUIDED IMAGERY; HUMAN; HYPNOSIS; MOTOR DYSFUNCTION; NONREM SLEEP; RELAXATION TRAINING; REVIEW; SLEEP WALKING; WAKEFULNESS;

ADULT; BENZODIAZEPINES; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; HYPNOSIS; HYPNOTICS AND SEDATIVES; IMAGERY (PSYCHOTHERAPY); PATIENT CARE TEAM; RELAXATION THERAPY; SOMNAMBULISM; SUGGESTION; YOUNG ADULT;

EID: 67449091375     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2008.09.003     Document Type: Review

References (33)

1. Plazzi G., Vetrugno R., Provini F., and Montagna P. Sleepwalking and other ambulatory behaviours during sleep. Neurol Sci 26 Suppl. 3 (2005) s193-s198
2. Hughes J.R. A review of sleepwalking (somnambulism): the enigma of neurophysiology and polysomnography with differential diagnosis of complex partial seizures. Epilepsy Behav 11 4 (2007) 483-491
3. Wills L., and Garcia J. Parasomnias: epidemiology and management. CNS Drugs 16 12 (2002) 803-810
4. Mahowald M.W. Parasomnias. Med Clin North Am 88 3 (2004) 669-678 ix
5. Giglio P., Undevia N., and Spire J.-P. The primary parasomnias. A review for neurologists. Neurologist 11 2 (2005) 90-97
6. Mahowald M.W., and Schenck C.H. Non-rapid eye movement sleep parasomnias. Neurol Clin 23 4 (2005) 1077-1106
7. Plante D.T., and Winkelman J.W. Parasomnias. Psychiatr Clin North Am 29 4 (2006) 969-987
8. Auger R. Sleep-related eating disorders. Psychiatry 3 11 (2006) 64-70
9. Ohayon M.M., Guilleminault C., and Priest R.G. Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry 60 4 (1999) 268-276 quiz 77
10. Hublin C., Kaprio J., Partinen M., Heikkila K., and Koskenvuo M. Prevalence and genetics of sleepwalking: a population-based twin study. Neurology 48 1 (1997) 177-181
11. Lecendreux M., Bassetti C., Dauvilliers Y., Mayer G., Neidhart E., and Tafti M. HLA and genetic susceptibility to sleepwalking. Mol Psychiatry 8 1 (2003) 114-117
12. ADRAC. Zolpidem and bizarre sleep related effects. Aust Adv Drug React Bull 26 1 (2007)
13. Pressman M.R. Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications. Sleep Med Rev 11 1 (2007) 5-30
14. Juszczak G.R., and Swiergiel A.H. Serotonergic hypothesis of sleepwalking. Med Hypotheses 64 1 (2005) 28-32
15. Espa F., Dauvilliers Y., Ondze B., Billiard M., and Besset A. Arousal reactions in sleepwalking and night terrors in adults: the role of respiratory events. Sleep 25 8 (2002) 871-875
16. Oliviero A., Della Marca G., Tonali P.A., Pilato F., Saturno E., Dileone M., et al. Functional involvement of cerebral cortex in adult sleepwalking. J Neurol 254 8 (2007) 1066-1072
17. Remulla A., and Guilleminault C. Somnambulism (sleepwalking). Expert Opin Pharmacother 5 10 (2004) 2069-2074
18. Kennedy G.A. A review of hypnosis in the treatment of parasomnias: nightmare, sleepwalking, and sleep terror disorders. Aust J Clin Exp Hypn 30 2 (Nov 2002) 99-155
19. Search strategies for MEDLINE in Ovid Syntax and the PubMed translation. Available from. [accessed 19.07.2008]
20. Reid W.H., Ahmed I., and Levie C.A. Treatment of sleepwalking: a controlled study. Am J Psychother 35 1 (1981) 27-37
21. Reid W.H., Haffke E.A., and Chu C.C. Diazepam in intractable sleepwalking: a pilot study. Hillside J Clin Psychiatry 6 1 (1984) 49-55
22. Guilleminault C., Kirisoglu C., Bao G., Arias V., Chan A., and Li K.K. Adult chronic sleepwalking and its treatment based on polysomnography. Brain 128 5 (2005) 1062-1069
23. Schenck C.H., Milner D.M., Hurwitz T.D., Bundlie S.R., and Mahowald M.W. A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry 146 9 (1989) 1166-1173
24. Schenck C.H., and Mahowald M.W. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 100 3 (1996) 333-337
25. Hurwitz T.D., Mahowald M.W., Schenck C.H., Schluter J.L., and Bundlie S.R. A retrospective outcome study and review of hypnosis as treatment of adults with sleepwalking and sleep terror. J Nerv Ment Dis 179 4 (1991) 228-233
26. Hauri P.J., Silber M.H., and Boeve B.F. The treatment of parasomnias with hypnosis: a 5-year follow-up study. J Clin Sleep Med 3 4 (2007) 369-373
27. Gazarian M., Kelly M., McPhee J.R., Graudins L.V., Ward R.L., and Campbell T.J. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust 185 10 (2006) 544-548
28. Mahowald MW, Cramer Bornemann MA. NREM sleep-arousal parasomnias in principles and practice of sleep medicine. Meir Kryger, Thomas Roth, William Dement, editors. Philadelphia: Elsevier Saunders; 2005. p 889-96. 4th ed.
29. Pressman M.R. Why has sleepwalking research been "sleepwalking"?. Neurology 70 24 (2008) 2274-2275
30. Lagakos S.W. Clinical trials and rare diseases. N Engl J Med 348 24 (2003) 2455-2456
31. Honkanen V.E., Siegel A.F., Szalai J.P., Berger V., Feldman B.M., and Siegel J.N. A three-stage clinical trial design for rare disorders. Stat Med 20 20 (2001) 3009-3021
32. Pilon M., Montplaisir J., and Zadra A. Precipitating factors of somnambulism: impact of sleep deprivation and forced arousals. Neurology 70 24 (2008) 2284-2290
33. Stone A.A., Shiffman S., Schwartz J.E., Broderick J.E., and Hufford M.R. Patient compliance with paper and electronic diaries. Control Clin Trials 24 2 (2003) 182-199